<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Access-related complications of percutaneous access for diagnostic or interventional procedures
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Access-related complications of percutaneous access for diagnostic or interventional procedures
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Access-related complications of percutaneous access for diagnostic or interventional procedures
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Matthew R Smeds, MD, FACS, DFSVS
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael C Soult, MD, RPVI, FACS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joseph L Mills, Sr, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John F Eidt, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kathryn A Collins, MD, PhD, FACS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 31, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H3919960256">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Complications after percutaneous access for peripheral procedures occur in up to 6 percent of patients [
         <a href="#rid1">
          1-3
         </a>
         ]. The most common complication is hematoma (minor or major), although pseudoaneurysm, arteriovenous fistula, arterial thrombosis, and embolization may also occur.
        </p>
        <p>
         Hemorrhage and hematoma typically occur within minutes to hours of sheath removal as evidenced by complaints of pain, focal mass, hypotension, or falling hematocrit, which lead to confirmatory noninvasive testing (ultrasound or computed tomography). By contrast, other complications such as pseudoaneurysm and arteriovenous fistula may not become apparent until days to weeks later.
        </p>
        <p>
         Arterial access techniques for percutaneous diagnostic and interventional vascular procedures are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/15192.html" rel="external">
          "Percutaneous arterial access techniques for diagnostic or interventional procedures"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2691864398">
         <span class="h1">
          GENERAL CONSIDERATIONS AND RISK FACTORS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Percutaneous access is used for various diagnostic and interventional vascular procedures including neurovascular, cardiac, mesenteric vascular, renovascular, and peripheral vascular disease. (See
         <a class="medical medical_review" href="/z/d/html/15192.html" rel="external">
          "Percutaneous arterial access techniques for diagnostic or interventional procedures", section on 'Introduction'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3205198895">
         <span class="h2">
          Treated conditions and access sites
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of access sites are used to treat a multitude of conditions using instrumentation designed to regain lumen diameter (eg, angioplasty, stenting, atherectomy), remove thrombus (thrombolysis, mechanical thrombectomy), create vascular occlusion (angioembolization for bleeding, coil embolization of aneurysm), deliver intravascular devices or medications, or retrieve foreign bodies.
        </p>
        <p>
         The access site is selected based on the location of the pathology being treated and the procedure planned. Thus, certain access sites and therefore access site complications are associated with some procedures more than others. (See
         <a class="medical medical_review" href="/z/d/html/15192.html" rel="external">
          "Percutaneous arterial access techniques for diagnostic or interventional procedures", section on 'Site selection'
         </a>
         .)
        </p>
        <p>
         Common access sites include the:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Common femoral artery (see
         <a class="medical medical_review" href="/z/d/html/15192.html" rel="external">
          "Percutaneous arterial access techniques for diagnostic or interventional procedures", section on 'Common femoral artery'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Brachial artery (see
         <a class="medical medical_review" href="/z/d/html/15192.html" rel="external">
          "Percutaneous arterial access techniques for diagnostic or interventional procedures", section on 'Brachial artery'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Radial artery (see
         <a class="medical medical_review" href="/z/d/html/15192.html" rel="external">
          "Percutaneous arterial access techniques for diagnostic or interventional procedures", section on 'Radial artery'
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         Other less commonly used sites for lower extremity procedures include the:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Popliteal artery (see
         <a class="medical medical_review" href="/z/d/html/15192.html" rel="external">
          "Percutaneous arterial access techniques for diagnostic or interventional procedures", section on 'Popliteal artery'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pedal arteries (see
         <a class="medical medical_review" href="/z/d/html/15192.html" rel="external">
          "Percutaneous arterial access techniques for diagnostic or interventional procedures", section on 'Pedal artery access'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H207844078">
         <span class="h2">
          Risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Risk factors for vascular access complications at any access site include [
         <a href="#rid1">
          1-14
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multiple access attempts
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Failure to use ultrasound guidance during needle access
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Periprocedural antithrombotic/fibrinolytic medications
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Larger needle at initial arterial access (18- versus 21-gauge needle)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Larger sheath size
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Longer sheath duration
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Repeat procedures
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Female sex
        </p>
        <p>
        </p>
        <p>
         Risk factors specific to the common femoral access site include [
         <a href="#rid15">
          15-21
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Common femoral artery atherosclerotic disease
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Use of intra-aortic balloon pump
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Inadvertent access of the external iliac or superficial femoral artery
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Closure device failure
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obesity
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1772124262">
         <span class="h1">
          LOCAL ACCESS COMPLICATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H677542053">
         <span class="h2">
          Access site bleeding
         </span>
         <span class="headingEndMark">
          —
         </span>
         Postprocedure bleeding following arterial access can be overt or lead to
         <strong>
         </strong>
         hematoma or pseudoaneurysm formation depending upon the degree the bleeding is contained. These bleeding complications have been reported at all access locations.
        </p>
        <p>
         Most hematomas can be managed conservatively with additional manual pressure and most resolve over a period of days, and surgical repair of the needle puncture site is generally not required. However, bleeding associated with femoral artery access can be significant and difficult to detect if extension to the retroperitoneum occurs (see
         <a class="local">
          'Retroperitoneal hematoma'
         </a>
         below). Hematoma formation in the soft tissue of the upper thigh can also occur, and the patient should be informed that the development of a large area of ecchymosis is possible.
        </p>
        <p>
         Nerve compression related to hematoma can occur. The need for and urgency of decompression depends upon the severity of symptoms and the access site location. Although most hematomas resolve over a period of days, femoral nerve compression can occur, which may take weeks to months to resolve. Brachial plexus or median nerve compression associated with axillary or brachial access can lead to severe limb dysfunction, and early recognition and treatment are necessary. (See
         <a class="local">
          'Axillary/brachial sheath hematoma'
         </a>
         below.)
        </p>
        <p>
         Anticoagulation using
         <a class="drug drug_general" data-topicid="8518" href="/z/d/drug information/8518.html" rel="external">
          unfractionated heparin
         </a>
         is used during most cardiac and peripheral vascular interventions to reduce the risk of thrombosis, but ongoing anticoagulation may make it more difficult to achieve hemostasis at the arterial access site. (See
         <a class="medical medical_review" href="/z/d/html/15192.html" rel="external">
          "Percutaneous arterial access techniques for diagnostic or interventional procedures", section on 'Hemostasis at the access site'
         </a>
         .)
        </p>
        <p>
         While access site bleeding is often related to administration of antithrombotic therapies, it is also related to the size of the sheath and duration of cannulation. Other risk factors for bleeding requiring transfusion have included female sex, which is explained in part, but not completely by smaller vessel size [
         <a href="#rid22">
          22
         </a>
         ], and older age (9 percent in a series of patients undergoing coronary intervention [
         <a href="#rid23">
          23
         </a>
         ]).
        </p>
        <p class="headingAnchor" id="H769435559">
         <span class="h3">
          Retroperitoneal hematoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Retroperitoneal bleeding represents a particularly serious type of preventable vascular complication. If the arterial puncture occurs proximal to the inguinal ligament, a hematoma may extend into the retroperitoneal space, causing hypotension and ipsilateral flank pain. This can be prevented in most cases by using ultrasound guidance during needle access and with careful attention to anatomic landmarks and fluoroscopy of the femoral head prior to needle puncture. (See
         <a class="medical medical_review" href="/z/d/html/15192.html" rel="external">
          "Percutaneous arterial access techniques for diagnostic or interventional procedures", section on 'Common femoral artery'
         </a>
         .)
        </p>
        <p>
         Retroperitoneal hemorrhage can also occur with puncture sites below the inguinal ligament, as blood can track along the vascular fascial sheath into the retroperitoneum or rectus sheath. Even with appropriate access position, back wall punctures that exit above the inguinal ligament may result in retroperitoneal bleeding and may not be sealed by manual compression or closure devices. Injudicious advancement of the guidewire or sheath by an inexperienced operator can also traumatize the iliac artery, lateral circumflex femoral artery, or inferior epigastric artery  (
         <a class="graphic graphic_figure graphicRef72956" href="/z/d/graphic/72956.html" rel="external">
          figure 1
         </a>
         ) and result in bleeding into the retroperitoneal space. A noncontrast computed tomography (CT) scan or abdominal ultrasonography can help to establish the diagnosis. Treatment is usually conservative if no active bleeding is noted (eg, bleeding through the wound, extravasation on CT scan), consisting of bed rest and blood transfusion rather than surgical correction. Reversal of systemic anticoagulation may be indicated if bleeding persists or is associated with hemodynamic compromise.
        </p>
        <p>
         If bleeding is active, percutaneous methods including balloon inflation or placement of a covered stent to tamponade or seal the bleeding segment may be useful for emergency treatment. Surgical management (vascular repair) is recommended for retroperitoneal bleeding with hemodynamic instability or ongoing transfusion requirements (&gt;2 units), which allows identification and control of bleeding point and evacuation of the hematoma. Some patients with severe ongoing pain may also benefit from exploration. Techniques for exploration are similar to those used to manage spontaneous retroperitoneal hematoma and are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/14928.html" rel="external">
          "Spontaneous retroperitoneal hematoma and rectus sheath hematoma", section on 'Surgical intervention'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2109229399">
         <span class="h3">
          Axillary/brachial sheath hematoma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Relative to other access sites, the complication rate for axillary or brachial access is high [
         <a href="#rid24">
          24,25
         </a>
         ]. In one review of 109 patients, the overall complication rate was 21 percent [
         <a href="#rid24">
          24
         </a>
         ]. Major complications occurred in 8.3 (1 of 12) for surgical cutdown via the brachial artery, 13.7 percent (7 of 51) for percutaneous puncture of the brachial artery, and 4.3 percent (2 of 46) for surgical cutdown of the axillary artery. Because of the association with neurologic complications, cutdown for access is commonly used.
        </p>
        <p>
         Hematoma or pseudoaneurysm after axillary or brachial access frequently leads to nerve compression given the limited space beneath the tight surrounding fascia. Due to the higher rates of compression of the brachial plexus, percutaneous axillary access has largely been abandoned. The location of brachial access affects the rates of complications. Distal brachial artery access is associated with lower rates of hematoma and subsequent nerve compression compared with more proximal access. (See
         <a class="medical medical_review" href="/z/d/html/15192.html" rel="external">
          "Percutaneous arterial access techniques for diagnostic or interventional procedures", section on 'Brachial artery'
         </a>
         .)
        </p>
        <p>
         Proximal brachial access has rates of hematoma and nerve compression similar to axillary access [
         <a href="#rid26">
          26
         </a>
         ]. Axillary and proximal brachial access hematomas with compression can take up to two weeks to present. Hematomas can spread along the brachial sheath and make detection more difficult. Also, brachial sheath hematoma at the antecubital fossa may not be visualized with ultrasound. Significant hand symptoms (pain, paresthesias) should prompt consideration of surgical exploration to prevent permanent neurological injury. Patients may present with numbness, pain, or weakness in median nerve distribution. However, they may have concomitant radial or ulnar neuropathies, or mononeuropathy in the ulnar or radial distribution [
         <a href="#rid27">
          27
         </a>
         ]. Therefore, it is imperative that interventionalists can prevent, diagnose, and rapidly treat brachial sheath hematomas to prevent permanent disability. (See
         <a class="medical medical_review" href="/z/d/html/14170.html" rel="external">
          "Traumatic peripheral neuropathies"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2663878649">
         <span class="h2">
          Pseudoaneurysm
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pseudoaneurysm following percutaneous access represents a false aneurysm due to an incomplete hemostatic plug at the injury site. Localized extravasation of blood outside the arterial wall is confined and controlled by the pseudocapsule that develops. The main risk factor for pseudoaneurysm formation is an inadequate period of manual compression. This was illustrated in a series of 581 angiographic procedures involving femoral artery catheterization [
         <a href="#rid28">
          28
         </a>
         ]. A pseudoaneurysm occurred in 14 percent of the first 300 procedures in which standard manual compression was performed, compared with 1.1 percent of the next 281 procedures when manual compression was continued for at least five minutes after local bleeding had stopped.
        </p>
        <p>
         Other risk factors include large-bore sheaths, postprocedural anticoagulation, antiplatelet therapy during the intervention, age &gt;65 years, obesity, hypertension, peripheral artery disease, hemodialysis, cannulation of the superficial rather than common femoral artery, and complex interventions [
         <a href="#rid28">
          28-30
         </a>
         ].
        </p>
        <p>
         A pseudoaneurysm is easily recognized by the presence of a pulsatile mass at the access site. Most pseudoaneurysms are evident within the first few days following percutaneous procedure [
         <a href="#rid29">
          29
         </a>
         ]. The clinical diagnosis is confirmed by ultrasonography, which demonstrates a typical yin-yang sign  (
         <a class="graphic graphic_diagnosticimage graphicRef118485" href="/z/d/graphic/118485.html" rel="external">
          image 1
         </a>
         ).
        </p>
        <p>
         Small pseudoaneurysms (&lt;3 cm for common femoral site) can be observed, and ultrasound-guided thrombin injection is used in those that persist or are symptomatic  (
         <a class="graphic graphic_algorithm graphicRef118805" href="/z/d/graphic/118805.html" rel="external">
          algorithm 1
         </a>
         ). This general principle can be applied at other access sites, although size criteria are not well defined. Due to low success rates and discomfort associated with ultrasound-guided manual compression, thrombin injection remains the treatment of choice.
        </p>
        <p>
         Pseudoaneurysm can occur at any access site, but the common femoral artery is the most common site for iatrogenic pseudoaneurysm. In a review of femoral artery pseudoaneurysms, 86 percent of pseudoaneurysms less than 3 centimeters in diameter resolved spontaneously. Femoral artery pseudoaneurysm is reviewed in detail separately [
         <a href="#rid31">
          31
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/113181.html" rel="external">
          "Femoral artery pseudoaneurysm following percutaneous intervention"
         </a>
         .)
        </p>
        <p>
         The success rate of ultrasound-guided injection of bovine thrombin was illustrated in a series of 240 patients with simple or complex pseudoaneurysms [
         <a href="#rid29">
          29
         </a>
         ]. The primary success rate was 96 percent with simple pseudoaneurysms and 89 percent with complex pseudoaneurysms. The secondary success rate was 99.6 percent (all but one patient). The authors also reviewed 34 studies with 1388 patients; the overall success rate was 97.2 percent [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
         Surgical management should be performed when a pseudoaneurysm becomes very large and threatens or causes skin necrosis or causes other symptoms, is expanding rapidly, or after failure of minimally invasive attempts to close the fistula [
         <a href="#rid30">
          30
         </a>
         ]. Expanding hematomas have a propensity toward eventual rupture, especially if the patient is maintained on anticoagulation [
         <a href="#rid1">
          1,3,32,33
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3809332320">
         <span class="h2">
          Arteriovenous fistula
         </span>
         <span class="headingEndMark">
          —
         </span>
         Arteriovenous fistula formation can occur at any access site. The clinical features are reviewed separately. Treatment is tailored to the extremity of the access site. (See
         <a class="medical medical_review" href="/z/d/html/8217.html" rel="external">
          "Acquired arteriovenous fistula of the lower extremity"
         </a>
         .)
        </p>
        <p>
         Ongoing bleeding from the arterial puncture site may decompress into an adjacent venous puncture, leading to the formation of an arteriovenous fistula. This complication may be recognized by the presence of a thrill or continuous bruit at the site of catheter insertion.
        </p>
        <p>
         Surgical repair is often necessary at the femoral access site since fistulae tend to enlarge over time. The most common finding at surgery is a puncture site below the common femoral artery, which underscores the importance of careful technique in avoiding this complication [
         <a href="#rid32">
          32
         </a>
         ]. These can also be repaired with placement of a covered stent to occlude the anomalous connection. Fistula formation at other access sites is individualized depending on the access site but can often be managed with observation. Repair should be considered if it is causing hemodynamic consequences (eg, increased cardiac output).
        </p>
        <p class="headingAnchor" id="H565465705">
         <span class="h1">
          CATHETER/SHEATH/WIRE COMPLICATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H2880506514">
         <span class="h2">
          Arterial thrombosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Arterial thrombosis is rare at lower extremity access sites and occurs slightly more often when the brachial approach is used [
         <a href="#rid34">
          34,35
         </a>
         ]. Predisposing factors to femoral artery thrombosis include small vessel lumen, peripheral artery disease, diabetes mellitus, female sex, placement of a large diameter catheter or sheath (eg, intra-aortic balloon pump, aortic stent grafting, etc), or a long catheter dwell time [
         <a href="#rid1">
          1,3,33-38
         </a>
         ]. Patients with lower extremity pain or paresthesia, plus reduced or absent distal pulses not responding to catheter removal, should be evaluated for possible flow obstructing thrombus or dissection. Urgent open or mechanical thrombectomy may be required for preservation of the limb. Thrombosis of the access site would typically require exploration, thromboendarterectomy, and patch closure. However, endovascular treatment using thrombectomy and stenting can be considered selectively in high-risk patients.
        </p>
        <p>
         Radial artery access is associated with a 5 to 19 percent risk of radial artery occlusion [
         <a href="#rid4">
          4,39
         </a>
         ]. Systemic anticoagulation and use of smaller sheaths may reduce the risk. This complication is usually not clinically important in most patients because the hand is perfused by both the radial and ulnar arteries with extensive collateral flow between the two. However, some patients have incomplete palmar arches, which may diminish collateral perfusion, possibly leading to hand ischemia in the presence of radial artery occlusion  (
         <a class="graphic graphic_figure graphicRef55221" href="/z/d/graphic/55221.html" rel="external">
          figure 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/15192.html" rel="external">
          "Percutaneous arterial access techniques for diagnostic or interventional procedures", section on 'Radial artery'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1094752553">
         <span class="h2">
          Embolism
         </span>
         <span class="headingEndMark">
          —
         </span>
         As a result of arterial access (any site), embolization can occur and may be related to atheromatous debris/thrombus or device components. The clinical features associated with embolism of various vascular beds are reviewed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8191.html" rel="external">
          "Endovascular repair of the thoracic aorta", section on 'Cerebrovascular ischemia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1104.html" rel="external">
          "Overview of carotid artery stenting", section on 'Stroke'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14083.html" rel="external">
          "Stroke after cardiac catheterization"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/14938.html" rel="external">
          "Embolism to the upper extremities"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/96754.html" rel="external">
          "Acute mesenteric arterial occlusion"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/8184.html" rel="external">
          "Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/112120.html" rel="external">
          "Embolism to the lower extremities"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1628812318">
         <span class="h3">
          Atheroembolism
         </span>
         <span class="headingEndMark">
          —
         </span>
         Stiff wires and large-bore guiding catheters can traumatize the aortic lumen, causing atheromatous debris to shear from the aortic wall. The reported incidence in cardiac catheterization series of atheroembolic events has ranged from 0.6 to 0.9 percent in retrospective studies to 1.4 to 1.9 percent in prospective series [
         <a href="#rid40">
          40,41
         </a>
         ]. The risk of atheroembolism can be reduced by avoiding the practice of readvancing a guidewire through the infrarenal aorta rather than exchanging it through a catheter.
        </p>
        <p>
         Distal microembolization can result in tissue loss and may be very difficult to treat. The clinical features of atheroembolism after diagnostic cardiac catheterization were examined in a prospective evaluation of 1786 patients ≥40 years of age [
         <a href="#rid40">
          40
         </a>
         ]. The following observations were made:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Twenty-five patients (1.4 percent) were diagnosed with atheroembolism; 12 had cutaneous signs (eg, "blue toes" syndrome, livedo reticularis)  (
         <a class="graphic graphic_picture graphicRef58761 graphicRef61842" href="/z/d/graphic/58761.html" rel="external">
          picture 1A-B
         </a>
         ), and 16 had acute renal failure that was considered to be atheroembolic in origin because it persisted for at least two weeks (while contrast nephropathy typically reverses within the first week).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Eosinophil counts were significantly higher in patients suffering from atheroembolism both before and after catheterization.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Four patients with atheroembolism died in the hospital (16 percent); all had progressive renal dysfunction. The mortality rate was much lower (0.5 percent) in the patients without atheroembolism.
        </p>
        <p>
        </p>
        <p>
         With lower extremity revascularizations, it is important to assess the patency of the runoff vessels before the procedure not only by reviewing preprocedural vascular imaging but also by injecting contrast after crossing occlusions to determine if any embolization has occurred during crossing. Filter protection can be considered when treating more distal lesions at high risk of embolization or during procedures known to be associated with higher risk of embolization, such as atherectomy procedures.
        </p>
        <p>
         Treatment of atheroembolism is largely supportive. Therapies that have been evaluated are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/8184.html" rel="external">
          "Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)", section on 'Instrumentation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4060952830">
         <span class="h3">
          Thromboembolism
         </span>
         <span class="headingEndMark">
          —
         </span>
         Thromboembolization related to the access site can occur with any type of endovascular intervention, and recognition of high-risk lesions is important to prevent this complication. Embolization due to manipulation of catheters in the iliac vessels can be related to soft iliac plaques or those containing fresh or organizing clots, which are more likely in subacute occlusions. For patients at high risk for embolization, femoral cutdown and clamping of the femoral artery before the intervention can be considered before proceeding with the recanalization (balloon angioplasty and stenting)  (
         <a class="graphic graphic_diagnosticimage graphicRef119081" href="/z/d/graphic/119081.html" rel="external">
          image 2
         </a>
         ).
        </p>
        <p>
         Once embolization has occurred, initial management includes ensuring adequate systemic anticoagulation. Embolization can be managed either using pharmacomechanical thrombolysis or by surgical thrombectomy, which may be more appropriate for patents with embolization of large thrombus to the common femoral artery. Removal can be attempted using a variety of thrombectomy catheters (suction, mechanical). Adjunctive thrombolysis will likely be necessary, and these devices may themselves cause additional embolization to more distal vessels, even with the use of protective distal filters during thrombectomy. Surgical embolectomy may be needed if embolic material cannot be adequately retrieved  (
         <a class="graphic graphic_diagnosticimage graphicRef119087" href="/z/d/graphic/119087.html" rel="external">
          image 3
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/112120.html" rel="external">
          "Embolism to the lower extremities"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H182411408">
         <span class="h2">
          Arterial dissection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dissection of the treated artery may occur during access to a severely diseased artery, unrecognized subintimal access, wire manipulation, or as part of crossing occlusions in a subintimal fashion, at the site of reentry, or after balloon angioplasty. When the anatomy is not clear, intravascular ultrasound can be helpful to identify the extent of the dissection. Stent placement may also be needed to tack down dissections that are flow limiting.
        </p>
        <p class="headingAnchor" id="H3406856887">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118637.html" rel="external">
          "Society guideline links: Acute extremity ischemia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H225969310">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Percutaneous access
         </strong>
         – Percutaneous access site complications for diagnostic or interventional procedures are uncommon overall, occurring in about 6 percent of patients. Such procedures include neurovascular, cardiac, mesenteric, renal, and peripheral vascular procedures. Percutaneous access sites include the common femoral artery, brachial artery, radial artery, pedal arteries, and less commonly the axillary artery. (See
         <a class="local">
          'General considerations and risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Categories
         </strong>
         – Complications of percutaneous access fall into two broad categories, including those related to the puncture site, which includes bleeding, hematoma, arteriovenous fistula, pseudoaneurysm, arterial dissection, and thrombosis, and those more typically related to access with wires and sheaths, including atheroembolism, thromboembolism, and vessel perforation. These complications can occur at any access site. Some are more common at a specific access site compared with others. (See
         <a class="local">
          'Local access complications'
         </a>
         above and
         <a class="local">
          'Catheter/sheath/wire complications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors
         </strong>
         – General risk factors for vascular access complications include periprocedural antithrombotic/fibrinolytic medications (prolonged, excessive), repeat procedure, larger sheath size, and prolonged sheath duration. In addition to these, risk factors specific to common femoral access, which is the most accessed site, include atherosclerotic plaque at the puncture site, obesity, use of intra-aortic balloon pump, and inadvertent access of the external iliac or superficial femoral artery. (See
         <a class="local">
          'Risk factors'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Access site
         </strong>
         <strong>
          bleeding
         </strong>
         – Bleeding (eg, hemorrhage, hematoma) is the most common complication at any access site. Bleeding typically occurs within minutes to hours of sheath removal, whereas other complications related to bleeding from the access site (eg, pseudoaneurysm, neurologic dysfunction) may not become apparent until days or weeks later. Most bleeding can be controlled with additional manual pressure, and surgical intervention to repair the puncture sites is not usually necessary. (See
         <a class="local">
          'Access site bleeding'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Common access sites
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Common femoral artery access
         </strong>
         – Bleeding and hematoma are the most common complications associated with femoral artery access. Bleeding extending into the retroperitoneum or deep thigh causing large hematomas can be difficult to detect. (See
         <a class="local">
          'Retroperitoneal hematoma'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Radial artery access
         </strong>
         – Thrombosis is the most common complication related to radial artery access. Most often thrombosis does not lead to significant symptoms. However, if the palmar arch is not intact, hand ischemia may result that needs to be addressed. (See
         <a class="local">
          'Arterial thrombosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Brachial artery access
         </strong>
         – As with common femoral access, bleeding complications are the most common; however, at this site, the adjacent median nerve is at risk for compression, which can lead to neuropathy, which in some cases can be permanent if hematoma is not recognized and treated in a timely manner. (See
         <a class="local">
          'Axillary/brachial sheath hematoma'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Muller DW, Shamir KJ, Ellis SG, Topol EJ. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 1992; 69:63.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carrozza JP Jr, Baim DS. Complications of directional coronary atherectomy: incidence, causes, and management. Am J Cardiol 1993; 72:47E.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Popma JJ, Satler LF, Pichard AD, et al. Vascular complications after balloon and new device angioplasty. Circulation 1993; 88:1569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fanaroff AC, Rao SV, Swaminathan RV. Radial Access for Peripheral Interventions. Interv Cardiol Clin 2020; 9:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shapiro SZ, Sabacinski KA, Mantripragada K, et al. Access-Site Complications in Mechanical Thrombectomy for Acute Ischemic Stroke: A Review of Prospective Trials. AJNR Am J Neuroradiol 2020; 41:477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhat T, Teli S, Bhat H, et al. Access-site complications and their management during transradial cardiac catheterization. Expert Rev Cardiovasc Ther 2012; 10:627.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toggweiler S, Leipsic J, Binder RK, et al. Management of vascular access in transcatheter aortic valve replacement: part 2: Vascular complications. JACC Cardiovasc Interv 2013; 6:767.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gonen KA, Hakyemez B, Erdogan C. Analysis of predictive and preventive factors for access complications associated with vascular closure devices in complicated endovascular procedures. Jpn J Radiol 2021; 39:1206.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanner T. Formation of transient complexes in the glutamate dehydrogenase catalyzed reaction. Biochemistry 1975; 14:5094.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ciprian Cacuci A, Krankenberg H, Ingwersen M, et al. Access Site Complications of Peripheral Endovascular Procedures: A Large, Prospective Registry on Predictors and Consequences. J Endovasc Ther 2021; 28:746.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stone PA, Campbell JE. Complications related to femoral artery access for transcatheter procedures. Vasc Endovascular Surg 2012; 46:617.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stone PA, Campbell JE, AbuRahma AF. Femoral pseudoaneurysms after percutaneous access. J Vasc Surg 2014; 60:1359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kalish J, Eslami M, Gillespie D, et al. Routine use of ultrasound guidance in femoral arterial access for peripheral vascular intervention decreases groin hematoma rates. J Vasc Surg 2015; 61:1231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramirez JL, Smith EJT, Zarkowsky DS, et al. Closure device use for common femoral artery antegrade access is higher risk than retrograde access. Ann Vasc Surg 2021; 76:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oneissi M, Sweid A, Tjoumakaris S, et al. Access-Site Complications in Transfemoral Neuroendovascular Procedures: A Systematic Review of Incidence Rates and Management Strategies. Oper Neurosurg (Hagerstown) 2020; 19:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaki A, Blank N, Alraies MC, et al. Access and closure management of large bore femoral arterial access. J Interv Cardiol 2018; 31:969.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lamb KM, Hirose H. Vascular Complications in Extracoporeal Membrane Oxygenation. Crit Care Clin 2017; 33:813.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Jong MM, Lorusso R, Al Awami F, et al. Vascular complications following intra-aortic balloon pump implantation: an updated review. Perfusion 2018; 33:96.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee MO, Jeong KU, Kim KM, Song YG. Risk Factors Affecting Complications of Access Site in Vascular Intervention through Common Femoral Artery. Niger J Clin Pract 2022; 25:85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gradinariu G, Lyons O, Musajee M, et al. Predictors of percutaneous access-related complications in aortic endovascular procedures: 'real-world' insights and a comparison to open access. Int Angiol 2022; 41:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chiarito M, Cao D, Nicolas J, et al. Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials. Catheter Cardiovasc Interv 2021; 97:1387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Argulian E, Patel AD, Abramson JL, et al. Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. Am J Cardiol 2006; 98:48.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sadeghi HM, Grines CL, Chandra HR, et al. Percutaneous coronary interventions in octogenarians. glycoprotein IIb/IIIa receptor inhibitors' safety profile. J Am Coll Cardiol 2003; 42:428.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lentz CM, Zogaj D, Wessel HK, et al. Brachial and Axillary Artery Vascular Access for Endovascular Interventions. Ann Vasc Surg 2022; 81:292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Wulp K, Thijs I, van Wely M, et al. Incidence and predictors of vascular complications in transaxillary TAVI. EuroIntervention 2020; 15:e1325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steve Lee K, Sos TA. Brachial Artery Access. Tech Vasc Interv Radiol 2015; 18:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sheth RA, Ganguli S. Closure of Alternative Vascular Sites, Including Axillary, Brachial, Popliteal, and Surgical Grafts. Tech Vasc Interv Radiol 2015; 18:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katzenschlager R, Ugurluoglu A, Ahmadi A, et al. Incidence of pseudoaneurysm after diagnostic and therapeutic angiography. Radiology 1995; 195:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krueger K, Zaehringer M, Strohe D, et al. Postcatheterization pseudoaneurysm: results of US-guided percutaneous thrombin injection in 240 patients. Radiology 2005; 236:1104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Webber GW, Jang J, Gustavson S, Olin JW. Contemporary management of postcatheterization pseudoaneurysms. Circulation 2007; 115:2666.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toursarkissian B, Allen BT, Petrinec D, et al. Spontaneous closure of selected iatrogenic pseudoaneurysms and arteriovenous fistulae. J Vasc Surg 1997; 25:803.
          </a>
         </li>
         <li class="breakAll">
          Baim, DS, Grossman, W. Complications of cardiac catheterization. In: Cardiac Catheterization, Angiography and Intervention, Baim, DS, Grossman, W (Eds), Williams &amp; Wilkins, Baltimore 1996. p.17.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wyman RM, Safian RD, Portway V, et al. Current complications of diagnostic and therapeutic cardiac catheterization. J Am Coll Cardiol 1988; 12:1400.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dorros G, Cowley MJ, Simpson J, et al. Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation 1983; 67:723.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kennedy JW. Complications associated with cardiac catheterization and angiography. Cathet Cardiovasc Diagn 1982; 8:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson LW, Lozner EC, Johnson S, et al. Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions. I. Results and complications. Cathet Cardiovasc Diagn 1989; 17:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Noto TJ Jr, Johnson LW, Krone R, et al. Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&amp;I). Cathet Cardiovasc Diagn 1991; 24:75.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laskey W, Boyle J, Johnson LW. Multivariable model for prediction of risk of significant complication during diagnostic cardiac catheterization. The Registry Committee of the Society for Cardiac Angiography &amp; Interventions. Cathet Cardiovasc Diagn 1993; 30:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenwood MJ, Della-Siega AJ, Fretz EB, et al. Vascular communications of the hand in patients being considered for transradial coronary angiography: is the Allen's test accurate? J Am Coll Cardiol 2005; 46:2013.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 2003; 42:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bashore TM, Gehrig T. Cholesterol emboli after invasive cardiac procedures. J Am Coll Cardiol 2003; 42:217.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 15202 Version 6.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1729869" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8213570" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Complications of directional coronary atherectomy: incidence, causes, and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8403304" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Vascular complications after balloon and new device angioplasty.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31733741" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Radial Access for Peripheral Interventions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32079599" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Access-Site Complications in Mechanical Thrombectomy for Acute Ischemic Stroke: A Review of Prospective Trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22651838" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Access-site complications and their management during transradial cardiac catheterization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23968697" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Management of vascular access in transcatheter aortic valve replacement: part 2: Vascular complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34216347" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Analysis of predictive and preventive factors for access complications associated with vascular closure devices in complicated endovascular procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/39" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Formation of transient complexes in the glutamate dehydrogenase catalyzed reaction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34137662" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Access Site Complications of Peripheral Endovascular Procedures: A Large, Prospective Registry on Predictors and Consequences.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22968347" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Complications related to femoral artery access for transcatheter procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25175631" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Femoral pseudoaneurysms after percutaneous access.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25595399" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Routine use of ultrasound guidance in femoral arterial access for peripheral vascular intervention decreases groin hematoma rates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33838236" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Closure device use for common femoral artery antegrade access is higher risk than retrograde access.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32365203" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Access-Site Complications in Transfemoral Neuroendovascular Procedures: A Systematic Review of Incidence Rates and Management Strategies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30456854" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Access and closure management of large bore femoral arterial access.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28887929" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Vascular Complications in Extracoporeal Membrane Oxygenation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28816093" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Vascular complications following intra-aortic balloon pump implantation: an updated review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35046200" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Risk Factors Affecting Complications of Access Site in Vascular Intervention through Common Femoral Artery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35112825" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Predictors of percutaneous access-related complications in aortic endovascular procedures: 'real-world' insights and a comparison to open access.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33507598" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16784919" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12906967" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Percutaneous coronary interventions in octogenarians. glycoprotein IIb/IIIa receptor inhibitors' safety profile.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34775017" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Brachial and Axillary Artery Vascular Access for Endovascular Interventions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31532395" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Incidence and predictors of vascular complications in transaxillary TAVI.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26070620" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Brachial Artery Access.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26070623" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Closure of Alternative Vascular Sites, Including Axillary, Brachial, Popliteal, and Surgical Grafts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7724767" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Incidence of pseudoaneurysm after diagnostic and therapeutic angiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16055694" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Postcatheterization pseudoaneurysm: results of US-guided percutaneous thrombin injection in 240 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17515479" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Contemporary management of postcatheterization pseudoaneurysms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9152307" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Spontaneous closure of selected iatrogenic pseudoaneurysms and arteriovenous fistulae.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9152307" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Spontaneous closure of selected iatrogenic pseudoaneurysms and arteriovenous fistulae.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2973480" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Current complications of diagnostic and therapeutic cardiac catheterization.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6218938" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7060118" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Complications associated with cardiac catheterization and angiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2720767" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Coronary arteriography 1984-1987: a report of the Registry of the Society for Cardiac Angiography and Interventions. I. Results and complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1742788" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Cardiac catheterization 1990: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&amp;I).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8269487" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Multivariable model for prediction of risk of significant complication during diagnostic cardiac catheterization. The Registry Committee of the Society for Cardiac Angiography&amp;Interventions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16325034" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Vascular communications of the hand in patients being considered for transradial coronary angiography: is the Allen's test accurate?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12875753" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12875754" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Cholesterol emboli after invasive cardiac procedures.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
